News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genovis Signs Agreement on Projects for Major Pharmaceutical Company



3/20/2013 9:52:00 AM

The one-year development project agreement on behalf of a customer is worth about USD 100,000. The project will adapt Genovis’ products from the protein characterization portfolio to the customer’s technology platform. “We look forward to launching this initiative together with our customer. This project demonstrates the interest in Genovis’ unique products and is a recognition of our skills and experience in characterizing antibody-based drugs,” says Sarah Fredriksson, CEO of Genovis.

Read at GlobeNewswire


comments powered by Disqus
Genovis
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES